版本:
中国

BRIEF-Delivra signs exclusive licensing deal with ARA-Avanti

May 10 Delivra Corp

* Delivra - signs exclusive licensing deal with ARA-Avanti Rx Analytics for hemp non-psychoactive cannabinoid, terpene and flavonoid formulations and products

* Delivra - with formulation and extraction beginning immediately, we expect products to be in natural product stores, grocery stores and pharmacies in 2018

* Delivra - co, Avanti will own intellectual property, and co will receive a royalty percentage on related gross sales of suite of natural products Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐